home / stock / canf / canf quote
Last: | $2.42 |
---|---|
Change Percent: | 0.83% |
Open: | $2.39 |
Close: | $2.40 |
High: | $2.4799 |
Low: | $2.36 |
Volume: | 17,622 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.42 | $2.39 | $2.4 | $2.4799 | $2.36 | 17,622 | 07-03-2024 |
$2.4 | $2.73 | $2.4 | $2.73 | $2.3 | 93,419 | 07-02-2024 |
$2.61 | $2.66 | $2.61 | $2.7079 | $2.55 | 41,943 | 07-01-2024 |
$2.58 | $2.6 | $2.58 | $2.69 | $2.55 | 89,798 | 06-28-2024 |
$2.56 | $2.67 | $2.56 | $2.7399 | $2.55 | 46,750 | 06-27-2024 |
$2.65 | $2.81 | $2.65 | $2.8399 | $2.61 | 62,754 | 06-26-2024 |
$2.84 | $2.91 | $2.84 | $3.02 | $2.7501 | 65,632 | 06-25-2024 |
$2.87 | $2.94 | $2.87 | $2.9699 | $2.76 | 63,764 | 06-24-2024 |
$2.725 | $2.77 | $2.725 | $2.78 | $2.62 | 39,842 | 06-21-2024 |
$2.71 | $2.72 | $2.71 | $2.84 | $2.6501 | 64,288 | 06-20-2024 |
$2.73 | $3 | $2.73 | $3.055 | $2.61 | 208,733 | 06-19-2024 |
$2.73 | $3 | $2.73 | $3.055 | $2.61 | 208,733 | 06-18-2024 |
$3.21 | $3.36 | $3.21 | $3.36 | $3.2 | 134,508 | 06-17-2024 |
$3.35 | $3.76 | $3.35 | $4.48 | $3.1 | 677,332 | 06-14-2024 |
$3.63 | $3.1 | $3.63 | $3.85 | $3 | 298,360 | 06-13-2024 |
$3.14 | $2.83 | $3.14 | $3.3 | $2.83 | 335,112 | 06-12-2024 |
$2.76 | $2.55 | $2.76 | $2.8452 | $2.52 | 141,084 | 06-11-2024 |
$2.53 | $2.5 | $2.53 | $2.59 | $2.41 | 64,601 | 06-10-2024 |
$2.47 | $2.51 | $2.47 | $2.56 | $2.4 | 39,843 | 06-07-2024 |
$2.5566 | $2.54 | $2.5566 | $2.59 | $2.35 | 61,163 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
Can-Fite Biopharma Ltd Sponsored ADR Website:
Liver cirrhosis treatment global market is estimated to reach $29.2 billion by 2030 Ramat Gan, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that addr...
The canine osteoarthritis market is projected to reach $3 billion by 2028 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announces that company scientists came up with breakthrough findings showing that the anti-cance...